A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046)

Exclusion Criteria

• •Breast-feeding, pregnant, or plan to become pregnant during the study
• •Not able to tell migraine attack from other headaches
• •Older than 50 years of age at migraine onset
• •Have more than 15 headache days per month or have taken medication for acute headache on more than 10 days per month in any of the 3 months before starting in the study
• •History of gastric or small intestinal surgery
• •History of heart attack, stroke, unstable angina, coronary artery bypass surgery or transient ischemic attack in the 3 months before starting in the study
• •Currently participating or have participated in a study with in investigational compound or device in the last 30 days